Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Celltrion today announced that the European Commission EC has granted marketing authorization for three products across two biosimilars Eydenzelt CTP aflibercept a biosimilar to Eylea to treat multiple retinal disorders including neovascular wet ager...
The International Hospital Federations Awards the premier annual awards programme for hospitals and healthcare organizations worldwide will celebrate years of rewarding excellence in healthcare leadership at the edition
CDMO Live has emerged as the definitive industry gathering bringing together Europes leading pharmaceutical outsourcing decisionmakers at Rotterdams World Trade Center this May putting the spotlight on this critical sector
TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH the worlds first Apixaban oral dissolving film ODF The study confirmed that TAH is bioequivalent to US and European reference Apixaban tablets
The leading pharmaceutical company in the Baltics Grindeks continues to strengthen its global presence by entering new export markets This year for the first time Grindeks products will be delivered to Panama The companys export markets already inclu...
Rznomics announced on the th that its anticancer drug RZ has received Fast Track Designation from the US Food and Drug Administration FDA for the treatment of Hepatocellular Carcinoma HCC
Nowadays artificial intelligence AI technology is profoundly reshaping the landscape of the pharmaceutical and healthcare industry As a global innovationdriven pharmaceutical and healthcare group Fosun Pharma places great emphasis on the transformati...
Samsung Bioepis Co Ltd today announced that the European Commission EC has granted marketing authorization for OBODENCE mg prefilled syringe and XBRYK mg vial denosumab biosimilars referencing Prolia and Xgeva formerly referred to as SB
Ono Pharmaceutical Co Ltd announced that the US Food and Drug Administration FDA has approved ROMVIMZA vimseltinib a kinase inhibitor for adult patients with symptomatic tenosynovial giant cell tumor TGCT for which surgical resection will potentially...
Kexing Biopharm Co Ltdrecently announced that the Investigational New Drug Application IND of GB Human Interferon b Inhalation Solution a selfdeveloped product by the Companys whollyowned subsidiary Shenzhen Kexing Pharmaceutical Co Ltd
